Michael Lichtenberg

Michael Lichtenberg

Chief Medical Officer and Director of the Angiology Department and Vascular Center

Vascular Centre Clinic Arnsberg, Arnsberg, DE

  • Radcliffe

Biography

Michael Lichtenberg, MD, FESC is the Chief Medical Officer and Director of the Angiology Department and Vascular Center at the Arnsberg Clinic in Arnsberg, Germany.

Dr. Lichtenberg earned his medical degree from the Heinrich-Heine Medical University of Dusseldorf, and also studied at the Tulane University School of Medicine in New Orleans, Louisiana and the Texas Heart Institute in Houston, Texas.

As esteemed Interventional Angiologist with 20 years of experience in endovascular interventions, Dr. Lichtenberg was elected to serve as Managing Director of the German Society for Angiology in 2017. In 2019, he was elected to serve as the society’s President.

Dr. Lichtenberg’s areas of clinical interest include deep venous intervention, peripheral artery disease, peripheral thrombosis and atherosclerosis.

In addition to his day-to-day work in interventional care, his main interest is the evaluation of new devices, techniques and procedures for the intervention of peripheral artery disease. Dr. Lichtenberg has performed a series of studies in this area and conducted many clinical trials.

Dr Michael Lichtenberg is Section Editor of Vascular and Endovascular Review Journal.

Read more

Media

Michael Lichtenberg,

CIRSE 23: The SUCCESS PTA Study

Michael Lichtenberg,

Watch time: 5m 3s
CIRSE 23: BIONETIC-TRA Study

Michael Lichtenberg,

Watch time: 4m 34s
Endovascular Treatment of Arterial Injuries

Maria Antonella Ruffino, Nicos Labropoulos, Mary Costantino, et al

Watch time: 10m 54s
Vessel Preparation and Debulking Strategies Staying in the Lumen

Michael Lichtenberg, Nicos Labropoulos, Mary Costantino, et al

Watch time: 13m 44s
SFA Disease and Supera Stent

Sanjay Patel, Nicos Labropoulos, Michael Lichtenberg, et al

Watch time: 1h 1m 15s
A New Route to Treating Iliac Lesions: Investigator Insights From the BIONETIC-TRA Study

Michael Lichtenberg,

Watch time: 8m 49s
VIVA 22: MIMICS-3D Registry: 36-Month Outcomes of BioMimics Stent

Michael Lichtenberg,

Watch time: 4m 6s
VIVA 22: Results From a Post-Market Study of the Rotarex®S Catheter

Michael Lichtenberg,

Watch time: 4m 6s

Michael Lichtenberg,

Watch time: 2m 39s (19 videos)
LINC 22: PRELUDE-BTK With Dr Lichtenberg: Serranator® PTA in Pts With PAD

Michael Lichtenberg,

Watch time: 2m 39s
LINC 22: BioMimics 3D Stent: Safety and Efficacy in Real-World Patients

Michael Lichtenberg,

Watch time: 2m 46s
LINC 22: P-MAX Study with Dr Lichtenberg: ASPIREX®S Endovascular System

Michael Lichtenberg,

Watch time: 2m 44s
MIMICS-3D Registry | Atherosclerosis

Michael Lichtenberg,

Watch time: 3m 14s

Stephen Black, Frank Arko, Koen Deloose, et al

Watch time: 11h 38m 9s (13 videos)

Konstantinos P Donas, Michael Lichtenberg, Gergana Todorova Taneva, et al

Watch time: 56m 56s
LINC 2021: PRESTIGE Trial Update

Michael Lichtenberg,

Watch time: 6m 49s
LINC 2021: Findings From the MIMICS-3D Registry

Michael Lichtenberg,

Watch time: 5m 12s
LINC 2021: The First-in-Human KANSHAS 1 Study Results

Michael Lichtenberg,

Watch time: 4m 35s

Michael Lichtenberg, Ramesh K Tripathi,

Watch time: 1h 17m 7s
LINC 2020: IVUS vs fluoroscopic guided recanalization for iliofemoral obstruction — Dr Michael Lichtenberg

Michael Lichtenberg,

Watch time: 2m 22s
LINC 2020: Prestige Pilot study — Dr Michael Lichtenberg

Michael Lichtenberg,

Watch time: 3m 36s
LINC 2020: Retrospective Analysis of the Tack® Device — Dr Michael Lichtenberg

Michael Lichtenberg,

Watch time: 1m 55s

Keywords

Angiology, Peripheral Artery Disease, Interventional Cardiology